LOGO
LOGO

Quoin Pharma's QRX003 - A New Hope For Fragile Skin?

By Prabha Kurup   ✉  | Published:  | Google News Follow Us  | Join Us
smoothskinwomanv2 16062026 lt

About 300 million people worldwide live with a rare disease. While these conditions are individually uncommon, the challenges they bring are shared by millions. One such condition is Peeling Skin Syndrome (PSS), a group of rare genetic disorders that cause the skin to peel continuously and tear easily. The hallmark symptom is persistent peeling of the skin.

The stock we are bringing to your attention today is that of Quoin Pharmaceuticals Ltd. (QNRX), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - Jun 08-12, 2026

June 12, 2026 17:14 ET
Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.